Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 107.00
-13.00 (-10.83%)
Aug 26, 2026, 12:17 PM CST
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 2.98 billion as of August 25, 2026. Its market cap has decreased by -28.68% in one year.
Market Cap
2.98B
Enterprise Value
2.45B
Revenue
332.21M
Ranking
n/a
PE Ratio
27.65
Stock Price
107.00
ChartMarket Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 2.98B, an increase of 101.60%. That is a compound annual growth rate of 25.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 2.43B | -33.81% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 6.28B |
| Hi-Clearance | 5.79B |
| WeLeader Biomedical | 3.32B |
| Applied BioCode | 2.88B |
| Medimaging Integrated Solution | 2.63B |
| A Plus Biotechnology | 2.54B |
| Wellell | 2.49B |
| Dynamic Medical Technologies | 2.04B |